Analysis of Discrepancies in Drug Indications Approved by the US FDA, Health Canada and the European Medicines Agency
Enrique Seoane-Vazquez, Ph.D.1, Tewodros Eguale, MD, PhD2, Rosa Rodriguez-Monguio, PhD, MS3, Kholoud Ghazawi1 and Gordon Schiff, MD4
(1)Massachusetts College of Pharmacy and Health Sciences, Boston, MA, (2)Massachusetts College of Pharmacy and Health Sciences (MCPHS) University, Boston, MA, (3)University of Massachusetts, Amherst, Amherst, MA, (4)Brigham and Women's Hospital, Boston, MA